Supriya Lifescience gets GMP certification from ANVISA Brazil

05 Jan 2024 Evaluate

Supriya Lifescience has received Good Manufacturing Practice (GMP) certification from the Regulatory Authority of Brazil, ANVISA for its manufacturing site in Lote Parshuram. This success in the rigorous GMP inspection underscores Supriya’s commitment to the highest quality standards and the excellence of its smart manufacturing practices. 

The clearance of this audit marks the successful registration of 8 APIs with CADIFA and will further enable smoother and faster registration of the company’s other APIs. This Successful Inspection paves the way for Supriya Lifescience to acquire more customers in the Brazilian Pharmaceutical market. 

Supriya Lifescience is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development.

Supriya Lifescience Share Price

637.70 13.85 (2.22%)
01-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.